Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study

OBJECTIVE: To evaluate the efficacy and safety of degarelix 3-month depot in Japanese patients with prostate cancer. METHODS: In this Phase II, open-label, parallel-group study, 155 Japanese prostate cancer patients were randomized to treatment with degarelix administered subcutaneously at a mainten...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozono, Seiichiro, Tsukamoto, Taiji, Naito, Seiji, Ohashi, Yasuo, Ueda, Takeshi, Nishiyama, Tsutomu, Maeda, Hideki, Kusuoka, Hidehito, Akazawa, Rio, Ito, Mototsugu, Akaza, Hideyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421626/
https://www.ncbi.nlm.nih.gov/pubmed/28334771
http://dx.doi.org/10.1093/jjco/hyx011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421626/
https://www.ncbi.nlm.nih.gov/pubmed/28334771
http://dx.doi.org/10.1093/jjco/hyx011

Ejemplares similares